These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 30871495)

  • 21. Germline genetic variants were interactively associated with somatic alterations in gastric cancer.
    Zhang X; Wang Y; Tian T; Zhou G; Jin G
    Cancer Med; 2018 Aug; 7(8):3912-3920. PubMed ID: 29923336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostate Cancer Genomics: Recent Advances and the Prevailing Underrepresentation from Racial and Ethnic Minorities.
    Tan SH; Petrovics G; Srivastava S
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29690565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Somatic and Germline Variants Affect Prognosis and Susceptibility in Prostate Cancer.
    Rocca C; Rocca G; Zampieri P; Dell'atti L; Bianchi N; Ippolito C; Aguiari G
    Anticancer Res; 2023 Jul; 43(7):2941-2949. PubMed ID: 37351993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutation screening and association study of the candidate prostate cancer susceptibility genes MSR1, PTEN, and KLF6.
    Bar-Shira A; Matarasso N; Rosner S; Bercovich D; Matzkin H; Orr-Urtreger A
    Prostate; 2006 Jul; 66(10):1052-60. PubMed ID: 16598737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post genome-wide association studies functional characterization of prostate cancer risk loci.
    Jiang J; Cui W; Vongsangnak W; Hu G; Shen B
    BMC Genomics; 2013; 14 Suppl 8(Suppl 8):S9. PubMed ID: 24564736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction Landscape of Inherited Polymorphisms with Somatic Events in Cancer.
    Carter H; Marty R; Hofree M; Gross AM; Jensen J; Fisch KM; Wu X; DeBoever C; Van Nostrand EL; Song Y; Wheeler E; Kreisberg JF; Lippman SM; Yeo GW; Gutkind JS; Ideker T
    Cancer Discov; 2017 Apr; 7(4):410-423. PubMed ID: 28188128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer.
    Quigley DA; Dang HX; Zhao SG; Lloyd P; Aggarwal R; Alumkal JJ; Foye A; Kothari V; Perry MD; Bailey AM; Playdle D; Barnard TJ; Zhang L; Zhang J; Youngren JF; Cieslik MP; Parolia A; Beer TM; Thomas G; Chi KN; Gleave M; Lack NA; Zoubeidi A; Reiter RE; Rettig MB; Witte O; Ryan CJ; Fong L; Kim W; Friedlander T; Chou J; Li H; Das R; Li H; Moussavi-Baygi R; Goodarzi H; Gilbert LA; Lara PN; Evans CP; Goldstein TC; Stuart JM; Tomlins SA; Spratt DE; Cheetham RK; Cheng DT; Farh K; Gehring JS; Hakenberg J; Liao A; Febbo PG; Shon J; Sickler B; Batzoglou S; Knudsen KE; He HH; Huang J; Wyatt AW; Dehm SM; Ashworth A; Chinnaiyan AM; Maher CA; Small EJ; Feng FY
    Cell; 2018 Jul; 174(3):758-769.e9. PubMed ID: 30033370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Germline mutations and prostate cancer: is it time to change treatment algorithms?
    Telvizian T; Mukherji D
    Chin Clin Oncol; 2020 Oct; 9(5):65. PubMed ID: 32921062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single cell genomics reveals activation signatures of endogenous SCAR's networks in aneuploid human embryos and clinically intractable malignant tumors.
    Glinsky GV
    Cancer Lett; 2016 Oct; 381(1):176-93. PubMed ID: 27497790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction analysis between germline genetic variants and somatic mutations in head and neck cancer.
    Feng G; Feng H; Qi Y; Wang T; Ni N; Wu J; Yuan H
    Oral Oncol; 2022 May; 128():105859. PubMed ID: 35428027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advancing precision medicine for prostate cancer through genomics.
    Roychowdhury S; Chinnaiyan AM
    J Clin Oncol; 2013 May; 31(15):1866-73. PubMed ID: 23589550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate Cancer Transcriptomic Regulation by the Interplay of Germline Risk Alleles, Somatic Mutations, and 3D Genomic Architecture.
    Yuan J; Houlahan KE; Ramanand SG; Lee S; Baek G; Yang Y; Chen Y; Strand DW; Zhang MQ; Boutros PC; Mani RS
    Cancer Discov; 2022 Dec; 12(12):2838-2855. PubMed ID: 36108240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exome-wide analysis of bi-allelic alterations identifies a Lynch phenotype in The Cancer Genome Atlas.
    Buckley AR; Ideker T; Carter H; Harismendy O; Schork NJ
    Genome Med; 2018 Sep; 10(1):69. PubMed ID: 30217226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Co-occurrent Alterations of Alzheimer's Genes and Prostate Cancer Genes in Prostate Cancer.
    Lehrer S; Rheinstein PH
    Cancer Genomics Proteomics; 2020; 17(3):271-275. PubMed ID: 32345668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Somatic Mutations in Prostate Cancer: Closer to Personalized Medicine.
    Alvarez-Cubero MJ; Martinez-Gonzalez LJ; Robles-Fernandez I; Martinez-Herrera J; Garcia-Rodriguez G; Pascual-Geler M; Cozar JM; Lorente JA
    Mol Diagn Ther; 2017 Apr; 21(2):167-178. PubMed ID: 27995550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of key pathways and genes in PTEN mutation prostate cancer by bioinformatics analysis.
    Sun J; Li S; Wang F; Fan C; Wang J
    BMC Med Genet; 2019 Dec; 20(1):191. PubMed ID: 31791268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. WWP1 Gain-of-Function Inactivation of PTEN in Cancer Predisposition.
    Lee YR; Yehia L; Kishikawa T; Ni Y; Leach B; Zhang J; Panch N; Liu J; Wei W; Eng C; Pandolfi PP
    N Engl J Med; 2020 May; 382(22):2103-2116. PubMed ID: 32459922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The mutational landscape of prostate cancer.
    Barbieri CE; Bangma CH; Bjartell A; Catto JW; Culig Z; Grönberg H; Luo J; Visakorpi T; Rubin MA
    Eur Urol; 2013 Oct; 64(4):567-76. PubMed ID: 23759327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined MYC Activation and Pten Loss Are Sufficient to Create Genomic Instability and Lethal Metastatic Prostate Cancer.
    Hubbard GK; Mutton LN; Khalili M; McMullin RP; Hicks JL; Bianchi-Frias D; Horn LA; Kulac I; Moubarek MS; Nelson PS; Yegnasubramanian S; De Marzo AM; Bieberich CJ
    Cancer Res; 2016 Jan; 76(2):283-92. PubMed ID: 26554830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Approaches to integrating germline and tumor genomic data in cancer research.
    Feigelson HS; Goddard KA; Hollombe C; Tingle SR; Gillanders EM; Mechanic LE; Nelson SA
    Carcinogenesis; 2014 Oct; 35(10):2157-63. PubMed ID: 25115441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.